Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: real-world evidence
Pertussis, caused by Bordetella pertussis, is a highly contagious respiratory disease that poses a significant risk to young infants, resulting in both severe morbidity and mortality [1]. Among infants with pertussis, approximately 4% of cases are fatal. Dramatic decreases in pediatric pertussis cases and deaths have resulted from infant vaccination programs, which include whole-cell vaccines based on killed B. pertussis and acellular pertussis (aP) vaccines using highly purified B. pertussis antigens [1]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 10, 2024 Category: Infectious Diseases Authors: Surasith Chaithonwongwatthana, Wassana Wijagkanalan, Nasamon Wanlapakorn, Librada Fortuna, Vilasinee Yuwaree, Chawanee Kerdsomboon, Indrajeet Kumar Poredi, Souad Mansouri, Pham Hong Thai, Yong Poovorawan Source Type: research

Who develops long COVID? Longitudinal pre-pandemic predictors of long COVID and symptom clusters in a representative Dutch population
Even though most people infected with severe acute respiratory syndrome coronavirus 2 (i.e., SARS-CoV-2), resulting in Coronavirus disease 2019 (COVID-19) fully recover [1,2], a considerable number of patients continues to experience prolonged symptoms, such as fatigue, neurocognitive problems, and smell and taste impairment [2]. This syndrome of lingering symptoms following COVID-19 is referred to as long COVID or post-COVID syndrome. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 10, 2024 Category: Infectious Diseases Authors: Isabel A.L. Slurink, Sophie C.M. van den Houdt, Ga ëtan Mertens Source Type: research

Temporal patterns of organ dysfunction in COVID-19 patients hospitalized in the intensive care unit: A group-based multitrajectory modelling analysis
Since 2019, there has been a global pandemic of patients infected with severe acute respiratory syndrome coronaviruses (SARS-CoV-2), with more than 700 million confirmed cases and more than 6 million deaths in more than 200 countries worldwide as of October 2023, according to the World Health Organization (WHO) [1]. SARS-CoV-2 acts on angiotensin-converting enzyme 2 (ACE2), which is widely expressed in a variety of tissues, such as the lung, kidney, and cardiovascular system [2], resulting in respiratory dysfunction (RD) and nonpulmonary organ dysfunction (nPOD). (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 9, 2024 Category: Infectious Diseases Authors: Jiafei Yu, Kai Zhang, Tianqi Chen, Ronghai Lin, Qijiang Chen, Chensong Chen, Minfeng Tong, Jianping Chen, Jianhua Yu, Yuhang Lou, Panpan Xu, Chao Zhong, Qianfeng Chen, Kangwei Sun, Liyuan Liu, Lanxin Cao, Cheng Zheng, Ping Wang, Qitao Chen, Qianqian Yang, Source Type: research

A severe case of Plasmodium falciparum malaria in a traveler returning from Kazakhstan, a malaria-free country
Malaria is a major life-threatening vector-borne disease caused by the genus Plasmodium. It is common in the tropics and subtropics, especially in Africa, where considerable efforts are made to reduce its incidence, and to eliminate it from endemic countries as well as preventing its re-emergence in countries that have been declared malaria-free. To date 104 countries, including Kazakhstan, have reached the status of being malaria-free [1]. Nonetheless, in 2022, 84 malaria endemic countries had an estimated 249 million malaria cases, a 5 million increase compared to 2021 [2], and still posing a major burden on human health...
Source: International Journal of Infectious Diseases - April 5, 2024 Category: Infectious Diseases Authors: Thirumalaisamy P. Velavan, Wim A. Fleischmann, Peter G. Kremsner Tags: Case Report Source Type: research

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1 and JN.1 six months after the BNT162b2 bivalent booster
An increase evasion of the SARS-CoV-2 virus towards vaccination strategies and natural immunity has been rapidly described notably due to mutations in the spike receptor binding domain (RBD) and the N-terminal domain (NTD)C. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 5, 2024 Category: Infectious Diseases Authors: Julien Favresse, Constant Gillot, Julien Cabo, Clara David, Jean-Michel Dogn é, Jonathan Douxfils Tags: Short Communication Source Type: research

Sociodemographic and clinical characteristics associated with maternal and congenital syphilis-A prospective study in Peru
Syphilis, one of the oldest known infectious diseases, is caused by a spirochetal pathogen Treponema pallidum subspecies pallidum (T. pallidum henceforth). The World Health Organization (WHO) estimates a global prevalence of 36 million cases of syphilis, with 6-12 million new infections occurring annually. Syphilis is an easily treatable disease because parenteral treatment with Benzathine penicillin G usually clears T. pallidum infection. Yet, inaccessibility to proper testing and treatment facilities in resource limited regions remains the major cause of the high incidence of syphilis around the world. (Source: Internati...
Source: International Journal of Infectious Diseases - April 5, 2024 Category: Infectious Diseases Authors: Cesar P Carcamo, Carlos Velasquez, Sandra C. Rocha, Arturo Centurion-Lara, Lorena Lopez-Torres, Nikhat Parveen Source Type: research

TCR αβ-depleted hematopoietic stem cell transplant and third-party CD45RA+ depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis
CD19 and CD22-targeted chimeric antigen receptor (CAR) T-cell therapy bridged to hematopoietic stem cell transplantation (HSCT) has emerged as an effective therapeutic approach for refractory/relapsed acute lymphoblastic leukemia [1,2]. However, despite successful therapy, patients remain vulnerable to viral infections caused by prolonged immune system deficiency. Human parvovirus (HPV) B19 infection is among the frequently encountered viral infections post-transplantation. Effective treatment for persistent HPV B19 infection in immunocompromised patients has yet to be established. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 5, 2024 Category: Infectious Diseases Authors: Manpin Zhang, Chengjuan Luo, Jianmin Wang, Hua Zhu, Changying Luo, Xia Qin, Xiaohang Huang, Yuchen Lin, Jing Chen Tags: Case Report Source Type: research

Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan
Streptococcus pneumoniae asymptomatically colonizes the nasopharynx, often causes pneumococcal disease in children and adults, and can enter the bloodstream to cause invasive pneumococcal disease (IPD). The most common presentation is bacteremic pneumonia, which accounts for approximately 60% of all adult IPD cases [1]. Adult patients with bacteremic pneumococcal pneumonia have a higher in-hospital mortality rate than those without bacteremia [2]. Therefore, understanding the diverse clinical aspects of pneumococcal infection is crucial for effective management and prevention strategies especially in adult population. (Sou...
Source: International Journal of Infectious Diseases - April 4, 2024 Category: Infectious Diseases Authors: Kosuke Tamura, Reiko Shimbashi, Ayu Kasamatsu, Bin Chang, Kenji Gotoh, Yoshinari Tanabe, Koji Kuronuma, Kengo Oshima, Takaya Maruyama, Masashi Nakamatsu, Shuichi Abe, Kei Kasahara, Junichiro Nishi, Yu Arakawa, Yuki Kinjo, Motoi Suzuki, Yukihiro Akeda, Kaz Source Type: research

Microbial aetiology of community-acquired pneumonia in hospitalized adults: a prospective study utilising comprehensive molecular testing
Community-acquired pneumonia (CAP) impacts global health, affecting all demographic groups but posing a severe threat to the elderly and individuals with underlying health conditions [1,2]. Historically, Streptococcus pneumoniae were considered the primary cause of CAP [3]. Infectious diseases, however, are ever-changing, influenced by demographic shifts, behavioural changes, and vaccination programs, necessitating updated re-evaluation of CAP aetiology [4 –6]. Additionally, there is a complex interplay between viral epidemics and bacterial infections, which can influence the incidence and severity of CAP [7]. (Source: I...
Source: International Journal of Infectious Diseases - April 3, 2024 Category: Infectious Diseases Authors: Dagfinn Lunde Markussen, Øyvind Kommedal, Siri Tandberg Knoop, Marit Helen Ebbesen, Rune Oskar Bjørneklett, Christian Ritz, Lars Heggelund, Elling Ulvestad, Sondre Serigstad, Harleen M.S. Grewal Source Type: research

An inconspicuous identification: isolation and identification of a novel Pichia species presenting as fungemia following cardiac surgery.
An 84-year-old woman with an implantable cardiac pacemaker and a history of temporal arteritis on chronic prednisone (7 mg/day) noted increasing bilateral lower extremity edema approximately 2 months prior to hospital admission. The patient, an avid traveler, was born in South Africa and moved to the United States Pacific Northwest in the early 1960s. An outpatient transthoracic echocardiogram demonstrated an ascending aortic aneurysm and moderate aortic stenosis. CT angiogram confirmed severe aneurysmal dilation of the ascending thoracic aorta (7.4 cm), aortic arch (4.7 cm), and descending thoracic aorta (3.7 cm). (Source...
Source: International Journal of Infectious Diseases - April 3, 2024 Category: Infectious Diseases Authors: Allorie T. Caldwell, Toni Gabald ón, Verónica Mixão, Nancy L. Wengenack, Benjamin P. Westley, Ryan W. Stevens Tags: Case Report Source Type: research

A Case of Tick-borne Yezo Virus Infection: Concurrent Detection in the Patient and Tick
The Yezo virus (YEZV) is a new nairovirus species identified in two presumed cases of tick-borne disease in Hokkaido, Japan, in 2019 and 2020 [1]. A retrospective examination of serum samples from 248 patients with suspected tick-borne disease in Hokkaido since 2014 identified YEZV RNA in five individuals [1]. Furthermore, a recent study involving 402 patients with tick bites in Northeastern China detected YEZV RNA in a single patient [2]. Infections attributable to tick-borne nairoviruses can cause severe symptoms in humans and are emerging as a global public health concern. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 3, 2024 Category: Infectious Diseases Authors: Yusuke Ogata, Tasuku Sato, Kanji Kato, Kazuhiro Kikuchi, Kazuya Mitsuhashi, Kei Watari, Kazuma Tamiya, Akiko Goto, Hiroki Yamaguchi, Ryo Hisada Tags: Case Report Source Type: research

Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: a population-based, retrospective cohort study
Coronavirus disease (COVID-19), an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with very wide-ranging symptoms. Although the most common symptoms derive from infection of the respiratory tract, several cutaneous manifestations of COVID-19 exist [1,2]. Among these, cases of vesicular lesions and herpes zoster (HZ)-compatible cutaneous manifestations were reported in patients infected with SARS-CoV-2 during the first year of the COVID-19 pandemic [3 –5]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 2, 2024 Category: Infectious Diseases Authors: Elisa Correcher-Mart ínez, Mónica López-Lacort, Cintia Muñoz-Quiles, Javier Díez-Domingo, Alejandro Orrico-Sánchez Source Type: research

Editorial Board
(Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 1, 2024 Category: Infectious Diseases Source Type: research

Supplement Title Page
(Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 1, 2024 Category: Infectious Diseases Source Type: research

A systematic review of immunosuppressive risk factors and comorbidities associated with the development of crusted scabies.
Crusted scabies (CS, historically referred to as Norwegian scabies), caused by a proliferation of Sarcoptes scabiei mites, is a highly contagious and severe dermatological infection characterised by hyperkeratotic skin scaling that can progress from loose and flaky skin to thick adherent crusts. While hands and feet are most commonly affected, the most severe cases have near total body surface involvement [1]. Without adequate treatment, secondary infections can develop leading to bacterial sepsis with historically high fatality [2]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - April 1, 2024 Category: Infectious Diseases Authors: Gianni Bergamin, Joshua Hudson, Bart J Currie, Kate E Mounsey Source Type: research